26.15
Heartflow Inc 주식(HTFL)의 최신 뉴스
HTFLHeartflow Inc Volatility & Greeks - Finviz
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? - AOL.com
HTFL News | HEARTFLOW INC (NASDAQ:HTFL) - ChartMill
HeartFlow, Inc. (HTFL) Receives a New Rating from Freedom Capital Markets - The Globe and Mail
HTFL Initiated Coverage by Freedom Capital Markets -- Rating Set to Buy - GuruFocus
HeartFlow Price Target Announced at $37.00/Share by Freedom Capital Markets - Moomoo
HeartFlow vs. NovoCure: Which Emerging Healthcare Stock Is a Better Buy in 2026? - AOL.com
Heartflow (HTFL) Sees Significant Drop in Stock Price - GuruFocus
Heartflow (HTFL) Experiences Significant Decline - GuruFocus
CCORF Maintains Heartflow(HTFL.US) With Buy Rating, Maintains Target Price $37 - Moomoo
HeartFlow, Inc. Actuals & Estimates (NASDAQ:HTFL) - TradingView
HeartFlow: Finding Its Flow, Outpacing Guidance (NASDAQ:HTFL) - Seeking Alpha
HeartFlow, Inc.(NasdaqGS: HTFL) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com
HeartFlow, Inc.(NasdaqGS: HTFL) dropped from Russell 3000 Value Benchmark - marketscreener.com
HeartFlow, Inc.(NasdaqGS: HTFL) dropped from Russell 2500 Value Benchmark - marketscreener.com
HeartFlow, Inc.(NasdaqGS: HTFL) dropped from Russell 2000 Value Benchmark - marketscreener.com
Heartflow Insider Sold Shares Worth $1,361,500, According to a Recent SEC Filing - marketscreener.com
HTFL Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Heartflow Inc For: 26 June By Investing.com - Investing.com Nigeria
Heartflow CEO John Farquhar sells $1.36m of HTFL stock By Investing.com - Investing.com Nigeria
HeartFlow Inc (HTFL) CEO John Farquhar Sells 38,900 Shares - GuruFocus
Heartflow CEO John Farquhar sells $1.36m of HTFL stock - Investing.com
Heartflow (HTFL) CEO pre-planned sale of 38,900 shares at $35 - Stock Titan
Heartflow's Q1 2026 Beat: Is This the Turning Point for HTFL - Kavout | AI
Form 144 Heartflow For: 24 June By Investing.com - Investing.com South Africa
38,900-share Form 144 notice for HTFL (NASDAQ: HTFL) - Stock Titan
Heartflow Inc (HTFL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Heartflow Inc (HTFL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Heartflow (HTFL) director Weldon awarded 16,075 stock options at $32.05 strike - Stock Titan
Heartflow (HTFL) director receives 16,075 stock options at $32.05 strike - Stock Titan
Heartflow (HTFL) awards director Julie Cullivan 16,075 stock options - Stock Titan
Heartflow (HTFL) director granted 16,075 stock options at $32.05 - Stock Titan
Heartflow (HTFL) director granted 16,075 stock options at $32.05 exercise price - Stock Titan
[Form 4] Heartflow, Inc. Insider Trading Activity - Stock Titan
Heartflow (NASDAQ: HTFL) holders back board picks, approve auditor - Stock Titan
Heartflow Inc (HTFL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Heartflow Inc (HTFL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Heartflow Inc (HTFL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Heartflow Inc (HTFL) Institutional Confidence - TradingKey
Heartflow Inc (HTFL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Heartflow Inc (HTFL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Heartflow (HTFL) CMO exercises 10,000 options under 10b5-1 plan - Stock Titan
16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap - Benzinga
자본화:
|
볼륨(24시간):